Skip header and navigation

Refine By

10 records – page 1 of 1.

Association of serum lipids and obesity with cardiovascular mortality.

https://arctichealth.org/en/permalink/ahliterature249415
Source
Br Med J. 1977 Nov 5;2(6096):1185-7
Publication Type
Article
Date
Nov-5-1977
Author
R. Pelkonen
E A Nikkilä
S. Koskinen
K. Penttinen
S. Sarna
Source
Br Med J. 1977 Nov 5;2(6096):1185-7
Date
Nov-5-1977
Language
English
Publication Type
Article
Keywords
Cardiovascular Diseases - complications - mortality
Cholesterol - blood
Finland
Follow-Up Studies
Humans
Hyperlipidemias - complications
Male
Middle Aged
Obesity - complications
Risk
Smoking - complications
Triglycerides - blood
Abstract
Serum lipid concentrations, relative body weight, and smoking habits were assessed in a cohort of 1648 middle-aged Finnish men who were subsequently followed for seven years. Multivariate analysis showed that serum triglyceride and cholesterol concentrations and smoking were all independently associated with cardiovascular mortality. High serum triglyceride concentrations increased the risk of cardiovascular death only when they exceeded 1.7 mmol/l (150 mg/100 ml), but this occurred at all cholesterol and relative body weight levels. Obesity influenced death rates only in men with raised serum lipid levels, while smoking was associated with increased mortality when any combination of the other factors was present. Men who had raised triglyceride concentrations combined with smoking or obesity had the highest risk of cardiovascular death.
Notes
Cites: J Lab Clin Med. 1957 Jul;50(1):152-713439279
Cites: J Biol Chem. 1952 Mar;195(1):357-6614938387
Cites: Lancet. 1973 May 5;1(7810):954-94121585
Cites: Lancet. 1972 Apr 22;1(7756):865-84111826
Cites: Clin Endocrinol Metab. 1976 Jul;5(2):367-751085233
Cites: Circulation. 1973 Nov;48(5):950-84751960
Cites: Circulation. 1972 Apr;45(4):815-285016014
Cites: Am J Cardiol. 1976 May;37(6):903-101266756
Cites: Metabolism. 1976 Mar;25(3):313-201250165
Cites: J Chronic Dis. 1975 Feb;28(2):109-231112866
Cites: Biometrika. 1967 Jun;54(1):167-796049533
PubMed ID
589076 View in PubMed
Less detail
Source
Acta Endocrinol Suppl (Copenh). 1984;262:5-6
Publication Type
Article
Date
1984
Author
R. Pelkonen
A. Reunanen
Source
Acta Endocrinol Suppl (Copenh). 1984;262:5-6
Date
1984
Language
English
Publication Type
Article
Keywords
Aged
Diabetes Mellitus, Type 2 - epidemiology
Female
Humans
Male
Middle Aged
Scandinavia
PubMed ID
6586041 View in PubMed
Less detail

[Estimation of risk in voluntary life- and disability insurance].

https://arctichealth.org/en/permalink/ahliterature252641
Source
Duodecim. 1975;91(16):922-7
Publication Type
Article
Date
1975
Author
R. Pelkonen
V A Antila
Source
Duodecim. 1975;91(16):922-7
Date
1975
Language
Finnish
Publication Type
Article
Keywords
Finland
Humans
Insurance, Health
Insurance, Life
Risk
PubMed ID
1204530 View in PubMed
Less detail

[Follow-up of treatment of the diabetic patient].

https://arctichealth.org/en/permalink/ahliterature103975
Source
Duodecim. 1990;106(9):774-81
Publication Type
Article
Date
1990
Author
R. Pelkonen
Author Affiliation
HYKS:n III sisätautien klinikka, Helsinki, Finland.
Source
Duodecim. 1990;106(9):774-81
Date
1990
Language
Finnish
Publication Type
Article
Keywords
Diabetes Mellitus - diagnosis - metabolism - therapy
Finland
Humans
Patient Education as Topic
Physical Examination
Self Care
Time Factors
PubMed ID
1670370 View in PubMed
Less detail

[Risk assessment and responsibility selection].

https://arctichealth.org/en/permalink/ahliterature216095
Source
Duodecim. 1995;111(17):1711-5
Publication Type
Article
Date
1995
Author
R. Pelkonen
T. Somer
Author Affiliation
Ylilääkri Jälleenvakuutusosakeyhtio Varma, Helsinki.
Source
Duodecim. 1995;111(17):1711-5
Date
1995
Language
Finnish
Publication Type
Article
Keywords
Eligibility Determination - legislation & jurisprudence
Finland
Humans
Insurance Claim Review - legislation & jurisprudence
Insurance, Health - legislation & jurisprudence
Probability
Risk assessment
PubMed ID
9273295 View in PubMed
Less detail

Seasonal variation of urinary calcium and oxalate excretion, serum 25(OH)D3 and albumin level in relation to renal stone formation.

https://arctichealth.org/en/permalink/ahliterature243651
Source
Scand J Urol Nephrol. 1982;16(2):155-61
Publication Type
Article
Date
1982
Author
I. Elomaa
S L Karonen
A L Kairento
R. Pelkonen
Source
Scand J Urol Nephrol. 1982;16(2):155-61
Date
1982
Language
English
Publication Type
Article
Keywords
Adult
Calcium - urine
Dihydroxycholecalciferols - blood
Female
Finland
Humans
Kidney Calculi - metabolism
Male
Middle Aged
Oxalates - urine
Oxalic Acid
Seasons
Serum Albumin - metabolism
Abstract
Seasonal variations in urinary calcium and oxalate excretion, serum 25(OH)D3 and albumin level were studied in 11 normo- and 11 hypercalciuric renal stone-formers, in 10 healthy subjects and in 14 long-stay hospital patients during one year. Serum albumin levels increased significantly during May--October in all four groups, whereas no significant changes occurred in serum calcium values when adjusted for differences in serum albumin concentration. Serum 25(OH)D3 level, urinary calcium and oxalate excretion were significantly higher during May--October than November--April in all except the long-stay hospital patients, whose corresponding values showed no seasonal changes and whose serum 25(OH)D3 levels as well as urinary calcium excretion were significantly lower than in the other three groups. The serum 25(OH)D3 level was significantly higher throughout the year in hypercalciuric than normocalciuric stone-formers. The hypercalciuric patients also passed more stones than the normocalciuric patients during a period of 9 years. There was a positive correlation between serum 25(OH)D3 and urinary calcium, between serum 25(OH)D3 and stone episodes and between urinary calcium and stone episodes. Because of this positive correlation, it might be useful to concentrate preventive therapy for recurrent renal stones to the light period only.
PubMed ID
7123167 View in PubMed
Less detail

[Treatment of hyperparathyroidism: why, how, when].

https://arctichealth.org/en/permalink/ahliterature222412
Source
Duodecim. 1993;109(11):1011-6
Publication Type
Article
Date
1993
Author
R. Pelkonen
Author Affiliation
HYKS:n III sisätautien klinikka, Helsinki, Finland.
Source
Duodecim. 1993;109(11):1011-6
Date
1993
Language
Finnish
Publication Type
Article
Keywords
Aged
Calcium - blood
Estrogen Replacement Therapy
Female
Finland - epidemiology
Humans
Hyperparathyroidism - blood - epidemiology - therapy
Parathyroidectomy
PubMed ID
8062664 View in PubMed
Less detail

10 records – page 1 of 1.